Intermedin
Wei Zhang, Lijun Wang, Fei Xiao et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2012
OBJECTIVE: Intermedin (IMD), a member of calcitonin family, was suggested to play a role in angiogenesis and cancer. The aim of this study was to investigate the role of IMD in the angiogenic process and the underlying mechanism, and the possibility for it to be used as a target for angiogenesis-based anticancer therapies. METHODS AND RESULTS: Using in vivo and in vitro 3-dimensional angiogenic models, we found that IMD induced a well-ordered vasculature with hierarchical structure and had a synergistic effect with vascular endothelial growth factor. Using RNA interference, real-time polymerase chain reaction, and Western blot analysis, we found that IMD alleviated the undesirable effects of vascular endothelial growth factor by restricting the excessive vessel sprouting and uneven lumen formation through the regulation of vascular endothelial-cadherin and identified its receptor on the endothelial cells. Both mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphoinositide 3-kinase/Akt activation were involved in the effects. Furthermore, using experimental tumor models, we demonstrated that IMD was involved in tumor angiogenesis, and the blockade of IMD severely impaired blood supply and eventually inhibited tumor growth. CONCLUSIONS: We demonstrated that IMD played a critical role in the vascular remodeling process and tumor angiogenesis and may serve as a novel target for the development of angiogenesis-based anticancer therapies.
Cited by 37 works. doi:10.1161/atvbaha.112.300185
Authors
References
- Angiogenesis in cancer and other diseases
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
- Molecular mechanisms and clinical applications of angiogenesis
- Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis
- VEGF receptor signalling ? in control of vascular function
- Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
- The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
- Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
- Targeting the tumour vasculature: insights from physiological angiogenesis